title: Serial dilutions on synthetic peptide-based assays can resolve dual seroreactivity to HIV-1 and HIV-2.
authors.forename: V
authors.initials: V
authors.lastname: Soriano
authors.forename: M
authors.initials: M
authors.lastname: Gutiérrez
authors.forename: A
authors.initials: A
authors.lastname: Heredia
authors.forename: R
authors.initials: R
authors.lastname: Bravo
authors.forename: O
authors.initials: O
authors.lastname: Aguilera
authors.forename: A
authors.initials: A
authors.lastname: Mas
authors.forename: I
authors.initials: I
authors.lastname: Hewlett
authors.forename: M
authors.initials: M
authors.lastname: Baquero
authors.forename: J
authors.initials: J
authors.lastname: González-Lahoz
mesh_terms: D004306:Dose-Response Relationship, Immunologic; D015483:HIV Antibodies / Q000276:immunology*; D015658:HIV Infections / Q000175:diagnosis*; D015497:HIV-1 / Q000235:genetics / Q000276:immunology*; D015498:HIV-2 / Q000235:genetics / Q000276:immunology*; D006801:Humans; D010455:Peptides / Q000276:immunology; D016133:Polymerase Chain Reaction; D011533:Proviruses / Q000235:genetics
chemical_list: D015483:HIV Antibodies; D010455:Peptides